Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Inhibition of telomerase is proposed to limit the growth of cancer cells by triggering telomere shortening and cell death. Telomere maintenance by telomerase is sufficient, in some cell types, to allow immortal growth. Telomerase has been shown to cooperate with oncogenes in transforming cultured primary human cells into neoplastic cells, suggesting that telomerase activation contributes to malignant transformation. Moreover, telomerase inhibition in human tumour cell lines using dominant-negative versions of TERT leads to telomere shortening and cell death. These findings have led to the proposition that telomerase inhibition may result in cessation of tumour growth. The absence of telomerase from most normal cells supports the potential efficacy of anti-telomerase drugs for tumour therapy, as its inhibition is unlikely to have toxic effects. Mice deficient for Terc RNA (encoding telomerase) lack telomerase activity, and constitute a model for evaluating the role of telomerase and telomeres in tumourigenesis. Late-generation Terc-/- mice show defects in proliferative tissues and a moderate increase in the incidence of spontaneous tumours in highly proliferative cell types (lymphomas, teratocarcinomas). The appearance of these tumours is thought to be a consequence of chromosomal instability in these mice. These observations have challenged the expected effectiveness of anti-telomerase-based cancer therapies. Different cell types may nonetheless vary in their sensitivity to t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“findings consistent with previous studies establishing that telomere dysfunction acts as a tumor suppressor when p53 function is intact (7, 8, 30, 48).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [48]
In the citing paper
“Loss of telomerase activity in mice has been shown to suppress tumorigenesis in various tumour models [13][14][15][16]”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [13]
In the citing paper
“In a transgenic breast cancer model driven by Polyoma Middle T antigen, telomere dysfunction significantly impaired not only tumor latency and penetrance but also reduced metastatic potential (90).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [90]
In the citing paper
“A similar finding was observed in a skin carcinogenesis model, in which late generation mTerc−/− mice produced 20-fold fewer skin tumors upon chemical carcinogenesis treatment of the skin compared to wild-type controls with long telomeres50.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [50]
Citations
Cites
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Self-citationTelomere elongation in immortal human cells without detectable telomerase activity
Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S., & Reddel, R. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00098.x · Cited by 1,279
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
Self-citationKiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
Inhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979 · cited 1×
“The appearance of these tumours is thought to be a consequence of chromosomal instability in these mic”
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
Quintanilla, M., Brown, K., Ramsden, M., & Balmain, A. (1986) · Nature · doi:10.1038/322078a0 · Cited by 859 · cited 1×
“H-RAS activation and telomerase upregulation are reported to occur in most DMBA-initiated papilloma”
Background
Research works printed but not linked: 1
- Hennings, H. Primary culture of keratinocytes from newborn mouse epidermis in medium with lowered levels of Ca2+. in Keratinocyte Methods (eds Leigh, I.M. & Watt, F.M.) 21–23 (Cambridge University Press, New York, 1994).
Cited by
Items 201–300 of 348
Telomeres and Telomerase: A Modern Fountain of Youth?
de Magalhães, J. P., & Toussaint, O. (2004) · Rejuvenation Research · doi:10.1089/1549168041553044 · Cited by 36
Dyskerin, telomerase and the DNA damage response
Gu, B.-W., Bessler, M., & Mason, P. J. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7265 · Cited by 31
Modeling aging and cancer in the telomerase knockout mouse
Chang, S. S. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.08.020 · Cited by 38
The telomerase cycle: normal and pathological aspects
Brunori, M., Luciano, P., Gilson, É., & G�li, V. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0616-2 · Cited by 33
Dual roles of telomere dysfunction in initiation and suppression of tumorigenesis
Cosme‐Blanco, W., & Chang, S. S. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.011 · Cited by 32
“A similar finding was observed in a skin carcinogenesis model, in which late generation mTerc−/− mice produced 20-fold fewer skin tumors upon chemical carcinogenesis treatment of the skin compared to wildtype controls with long telomeres (Gonzalez-Suarez et al., 2000).”
ResultShort and dysfunctional telomeres sensitize the kidneys to develop fibrosis
Saraswati, S., Martínez, P., Graña-Castro, O., & Blasco, M. A. (2021) · Nature Aging · doi:10.1038/s43587-021-00040-8 · Cited by 28
Self-citationDissecting the non-canonical functions of telomerase
Parkinson, E. K., Fitchett, C., & Cereser, B. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167813 · Cited by 29
“Both canonical (Gonzalez-Suarez et al., 2000) and NC I (Gonzalez-Suarez et al., 2001; Cayuela et al., 2005) functions of the telomerase enzyme appear to be essential for neoplasia.”
BackgroundInfluentialTRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts
Brunori, M., Mathieu, N., Ricoul, M., Bauwens, S., Koering, C., de Climens, A. R., Belleville, A., Wang, Q., Puisieux, I., Décimo, D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209135 · Cited by 29
“Both in vitro and in vivo, overexpression of telomerase in cancer cells appears to be crucial for tumor progression (Greenberg et al., 1999; Hahn et al., 1999a, b; Gonzalez-Suarez et al., 2000, 2001; Elenbaas et al., 2001; Artandi et al., 2002).”
BackgroundReconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones
Biroccio, A., Amodei, S., Benassi, B., Scarsella, M., Cianciulli, A. M., Mottolese, M., Bufalo, D. D., Leonetti, C., & Zupi, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205415 · Cited by 27
“…with studies showing that telomerase de®cient mice, with short telomeres, are resistant to tumor development in multi-stage skin carcinogenesis (Gonzalez-Suarez et al., 2000a), while increased epidermal tumors has been found in transgenic mice overexpressing mTERT in basal keratinocytes…”
BackgroundMammalian meiotic telomeres: composition and ultrastructure in telomerase-deficient mice
Franco, S., Alsheimer, M., Herrera, E., Benavente, R., & Blasco, M. A. (2002) · European Journal of Cell Biology · doi:10.1078/0171-9335-00259 · Cited by 28
Self-citationWiemann, S. U., Ande, S., Buer, J., Kamino, K., Manns, M. P., & Rudolph, K. L. (2004) · Oncogene · doi:10.1038/sj.onc.1208308 · Cited by 24
Gire, V. (2005) · médecine/sciences · doi:10.1051/medsci/2005215491 · Cited by 40
Wang, Y., Xu, Q., Sack, L. M., Kang, C., & Elledge, S. J. (2016) · Genes & Development · doi:10.1101/gad.271445.115 · Cited by 24
“Consistently, in vivo studies using mouse models with genetically abolished telomerase activity show reduced incidence of tumorigenesis, demonstrating a positive role of senescence in tumor suppression [111] [112] [113].”
BackgroundSuppression of human tumor cell proliferation by Smurf2‐induced senescence
Zhang, H., Teng, Y., Kong, Y., Kowalski, P. E., & Cohen, S. N. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21337 · Cited by 23
“…which ordinarily is produced at a high level in mouse somatic cells and prevents telomere shortening in these cells (Prowse and Greider, 1995; Greenberg et al., 1998), undergo gradual loss of telomeres and induction of senescence, and become resistant to neoplasia (Greenberg et al., 1999;…”
BackgroundJaskelioff, M., Song, W., Xia, J., Liu, C., Kramer, J., Koido, S., Gendler, S. J., Calderwood, S. K., & Gong, J. (2009) · Oncogene · doi:10.1038/onc.2009.268 · Cited by 23
“, 1997) and activation of the DNA damage response pathway, leading to tumor suppression as a result of increased cellular apoptosis and senescence (Chin et al., 1999; Gonzalez-Suarez et al., 2000; Farazi et al., 2003; Cosme-Blanco et al., 2007).”
Assessing ageing of individual T lymphocytes: Mission impossible?
Iancu, E. M., Speiser, D. E., & Rufer, N. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.005 · Cited by 23
González‐Suárez, E., Goytisolo, F. A., Flores, J. M., & Blasco, M. A. (2003) · PubMed · Cited by 26
Self-citationStout, G. J., & Blasco, M. A. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.002121 · Cited by 21
“Q-FISH telomere length analysis Perpendicular sections of neonatal mouse skin were cut, deparaffinized and incubated with a Cy3-labeled telomeric peptide nucleic acid (PNA) probe (Gonzalez-Suarez et al., 2000; GonzalezSuarez et al., 2001).”
MethodSelf-citationSelective pressures for and against genetic instability in cancer: a time-dependent problem
Komarova, N. L., Sadovsky, A. V., & Wan, F. Y. M. (2007) · Journal of The Royal Society Interface · doi:10.1098/rsif.2007.1054 · Cited by 23
“It is shown that short telomeres can make mice resistant to skin cancer due to an increased cell death rate (Gonzalez-Suarez et al. 2000) which also suggests that telomerase activation and reduction in the level of chromosomal instability may be a necessary step for cancer to develop.”
BackgroundHahn, W. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.007 · Cited by 23
The use of covariance models to annotate RNAs in whole genomes
Gardner, P. P. (2009) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elp042 · Cited by 21
“ease [11–14].”
Complex roles for telomeres and telomerase in breast carcinogenesis
Artandi, S. E. (2002) · Breast Cancer Research · doi:10.1186/bcr553 · Cited by 25
“Telomere uncapping in late-generation mTERC–/– p53+/+ mice resulted in impaired tumor formation when these mice were treated with chemical carcinogens [11], or studied on an INK4A–/– [12] or APC+/– [13] tumor-prone background.”
BackgroundStem cell function and maintenance – ends that matter: Role of telomeres and telomerase
Saeed, H., & Iqtedar, M. (2013) · Journal of Biosciences · doi:10.1007/s12038-013-9346-3 · Cited by 24
“1999) and are resistant to skin carcinogenesis (Gonzalez-Suarez et al. 2000).”
BackgroundInfluentialde Grey, A. D. N. J., Campbell, F. C., Dokal, I. S., Fairbairn, L., Graham, G. J., Jahoda, C. A. B., & PORTERG, A. C. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.026 · Cited by 19
“Other models of cancer in TERC mice also show resistance to cancer progression.(72)”
BackgroundAging and cancer in transgenic and mutant mice
Anisimov, V. N. (2003) · Frontiers in bioscience · doi:10.2741/1122 · Cited by 19
PinX1: a sought-after major tumor suppressor at human chromosome 8p23
Zhou, X. Z. (2011) · Oncotarget · doi:10.18632/oncotarget.339 · Cited by 18
“However, it has been well documented that telomere shortening due to knockout of telomerase activates DNA damage pathways, limits cell proliferation and inhibits tumorigenesis in a number of mouse models [46-50].”
How Does Cellular Senescence Prevent Cancer?
Lynch, M. (2006) · DNA and Cell Biology · doi:10.1089/dna.2006.25.69 · Cited by 19
“Similarly, cells from late-generation telomerase knockout mice have accelerated cellular senescence in vitro (Greenberg et al. , 1999; Gonzalez-Suarez et al. , 2000) and a reduced incidence of certain malignancies lignancies is actually increased in late generation telomerase knockout mice (Rudolph…”
Telomerase as a novel and potentially selective target for cancer chemotherapy
Parkinson, E. K. (2003) · Annals of Medicine · doi:10.1080/07853890310006361 · Cited by 19
Anticancer Therapy Targeting Telomeres and Telomerase: Current Status
Parkinson, E. K., & Minty, F. (2007) · BioDrugs · doi:10.2165/00063030-200721060-00005 · Cited by 22
Telomere Dysfuction Promotes Metastasis in a TERC Null Mouse Model of Head and Neck Cancer
Bojović, B., & Crowe, D. L. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0345 · Cited by 21
“Previous studies using the DMBA/12 O tetradecanoylphorbol l3 acetate (TPA) mouse skin carcinogenesis protocol showed that telomerase deficient mice were resistant to tumor formation (30).”
Effectors of mammalian telomere dysfunction: a comparative transcriptome analysis using mouse models
Franco, S., Canela, A., Klatt, P., & Blasco, M. A. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi107 · Cited by 28
Self-citationMouse models to study the role of telomeres in cancer, aging and DNA repair
Blasco, M. A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00450-1 · Cited by 18
Self-citationDynamics of telomeric chromatin at the crossroads of aging and cancer
Ye, J., Wu, Y., & Gilson, É. (2010) · Essays in Biochemistry · doi:10.1042/bse0480147 · Cited by 17
Argilla, D., Chin, K., Singh, M., Hodgson, J. G., Bosenberg, M., Ortíz-de-Solórzano, C., Lockett, S. J., DePinho, R. A., Gray, J. W., & Hanahan, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.032 · Cited by 19
Aviv, A., & Harley, C. B. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0029-3 · Cited by 17
Engineering cancer resistance in mice
Klatt, P., & Serrano, M. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg057 · Cited by 16
Telomere and Its Role in Diseases
Wang, S., Madu, C. O., & Lu, Y. W. (2019) · Oncomedicine · doi:10.7150/oncm.28210 · Cited by 18
“[43] It is currently known that replicative senescence arises when progressive reduction of telomere length ends up with t-loop collapse and dysfunctional telomeres.”
Backgroundde Grey, A. D. N. J. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.436 · Cited by 15
“asserted that telomerase ablation has not yet been shown to prevent cancer in animal models and that no evidence exists that aspects of ageing can be reversed by phenacyldimethylthiazolium chloride, both contrary to reports published in top journals at least five years ago.(6,7) (Telomerase ablation would have major s…”
Escoffier, E., Rezza, A., de Climens, A. R., Belleville, A., Gazzolo, L., Gilson, É., & Dodon, M. D. (2005) · Retrovirology · doi:10.1186/1742-4690-2-77 · Cited by 19
Multi-omics and single cell characterization of cancer immunosenescence landscape
Wei, Q., Chen, R., He, X., Qu, Y., Yan, C., Liu, X., Liu, J., Luo, J., Yu, Z., Hu, W., et al. (2024) · Scientific Data · doi:10.1038/s41597-024-03562-z · Cited by 14
Hartwig, F. P., & Collares, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.03.003 · Cited by 11
Bejarano, L., Louzame, J., Montero, J. J., Megías, D., Flores, J. M., & Blasco, M. A. (2019) · iScience · doi:10.1016/j.isci.2019.08.012 · Cited by 11
Self-citationKanzaki, Y., Onoue, F., Sakurai, H., & Ide, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00717-4 · Cited by 15
Analysis and validation of aging-related genes in prognosis and immune function of glioblastoma
Mu, J., Gong, J., Shi, M., & Zhang, Y. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01538-3 · Cited by 11
“Similar results have been reported in skin tumors [18], pulmonary tumors [19], and breast tumors [20].”
ResultIn vivo role of checkpoint kinase 2 in signaling telomere dysfunction
Beccaria, M. G., Martínez, P., Flores, J. M., & Blasco, M. A. (2014) · Aging Cell · doi:10.1111/acel.12237 · Cited by 11
“Terc deficiency has been previously shown to have a potent tumor suppressor effect with increasing mouse generations (Greenberg et al., 1998; Lee et al., 1998; Rudolph et al., 1999; Gonzalez-Suarez et al., 2000).”
Self-citationSenescence and Senescence-Related Disorders
Wang, Z. P., & Inuzuka, H. (2013) · InTech eBooks · doi:10.5772/56158 · Cited by 12
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer
Nanni, S., Narducci, M., Pietra, L. D., Moretti, F., Grasselli, A., Carli, P. D., Sacchi, A., Pontecorvi, A., & Farsetti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215552 · Cited by 10
Sahm, V., Maurer, H. C., Baumeister, T., Anand, A., Strangmann, J., Schmid, R. M., Wang, T. C., & Quante, M. (2022) · Oncotarget · doi:10.18632/oncotarget.28198 · Cited by 10
“Investigations of other cancer-prone mouse models with dysfunctional telomeres have consistently noted impaired tumor development [18, 19, 40, 41] with increased levels of senescence and/ or apoptosis.”
BackgroundPrindull, G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.07.009 · Cited by 9
Heregulin, a new regulator of telomere length in human cells
Menéndez, J. A., Rubio, M. A., Campisi, J., & Lupu, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4964 · Cited by 9
“Whereas telomere attrition due to the absence of telomerase activity (for instance, Terc or Tert knock-out mice) has been shown to suppress tumor growth [52-54], short telomeres have been described to generate chromosome instability, which in turn may lead to an increased risk of developing several cancers [55, 56].”
BackgroundArsenic-Induced Mutagenesis and Carcinogenesis
Maiti, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-418688-0.00009-5 · Cited by 11
Télomère et cancer : quoi de plus à la fin ?
Brunori, M., & Gilson, É. (2005) · médecine/sciences · doi:10.1051/medsci/200521137 · Cited by 15
“À l’inverse, chez la souris, l’inactivation de la télomérase rend les animaux plus résistants à la progression de certains cancers induits expérimentalement [6, 9-11].”
BackgroundRegulation of telomerase towards tumor therapy
Yan, S., Song, L., Qiu, H., Wang, X., He, Y., Wang, C., & Huang, Y. Y. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01181-6 · Cited by 11
“Early generations of TERC − / − mouse seem to have epithelial cancer resistance, indicating that telomerase is associated with cancer development which depends on telomere length [24].”
BackgroundTelomeres, cancer & aging: live long & prosper?
Eissenberg, J. C. (2013) · Europe PMC (PubMed Central) · Cited by 12
A Review of the Repair of DNA Double Strand Breaks in the Development of Oral Cancer
Prime, S. S., Darski, P., Hunter, K. D., Cirillo, N., & Parkinson, E. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074092 · Cited by 11
McAloney, C. A., Silverstein, K. A. T., Modiano, J. F., & Bagchi, A. (2014) · BMC Veterinary Research · doi:10.1186/1746-6148-10-20 · Cited by 8
“Interestingly, it has also been observed that while deficient telomerase activity results in a decreased rate of cancer in mice [3], overexpression and ubiquitious expression of telomerase result in an increased rate of tumors [4].”
Blasco, M. A. (2001) · BioMed Research International · doi:10.1155/s1110724301000109 · Cited by 10
“In this regard, the skin of telomerase-deficient mice is resistant to chemical tumorigenesis [15].”
BackgroundSelf-citationCibler les télomères pour forcer les cellules cancéreuses à rentrer en sénescence
Londoño‐Vallejo, A., Lenain, C., & Gilson, É. (2008) · médecine/sciences · doi:10.1051/medsci/2008244383 · Cited by 13
“En accord avec un rôle oncosuppressif du dysfonctionnement télomérique chez l’homme, les souris de génération tardive, présentant des télomères courts, sont résistantes à certains processus de cancérisation [25-28].”
Canonical and non-canonical functions of the non-coding RNA component (TERC) of telomerase complex
Cao, C., Gong, W., Shuai, Y., Rasouli, S., Ge, Q., Anam Qadir, K. H. A. N., Dakic, A., Putluri, N., Shvets, G. B., Zheng, Y., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01367-0 · Cited by 13
“Early reports indicating a reduced papilloma frequency in TERC-deficient cells suggested a potential correlation between TERC and viruses [181].”
Telomerase and Cancer: A Complex Relationship
Fossel, M., & Whittemore, K. (2021) · OBM Geriatrics · doi:10.21926/obm.geriatr.2101156 · Cited by 7
Endogenous anticancer mechanisms EACMs
Lenz, G. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s315 · Cited by 8
Fastest Time to Cancer by Loss of Tumor Suppressor Genes
Sanchez‐Tapia, C., & Wan, F. Y. M. (2014) · Bulletin of Mathematical Biology · doi:10.1007/s11538-014-0027-7 · Cited by 8
Manipulating mouse telomeres: models of tumorigenesis and aging
Xin, Z., & Broccoli, D. (2004) · Cytogenetic and Genome Research · doi:10.1159/000078221 · Cited by 9
“Interestingly, late generation mTerc–/– mice showed significantly fewer skin tumors than wild type controls following chemical carcinogenesis (Gonzalez-Suarez et al., 2000), suggesting that tumor formation in skin requires telomere maintenance above a threshold length.”
BackgroundBapat, B. V., & Perera, S. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/38427 · Cited by 6
Telomerase flies the coop: the telomerase RNA component as a viral-encoded oncogene
Artandi, S. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060849 · Cited by 7
LRP::FLAG Reduces Phosphorylated Tau Levels in Alzheimer’s Disease Cell Culture Models
Cuttler, K., Bignoux, M. J., Otgaar, T. C., Chigumba, S., Ferreira, E., & Weiss, S. F. T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200244 · Cited by 7
TERT promoter alterations could provide a solution for Peto’s paradox in rodents
Vedelek, B., Maddali, A. K., Davenova, N., Vedelek, V., & Boros, I. (2020) · Scientific Reports · doi:10.1038/s41598-020-77648-0 · Cited by 6
Multistage Carcinogenesis: Cell and Animal Models
Kulesz-Martin, M. F., Ouyang, X., Barling, A. N., Gallegos, J. R., Liu, Y., & Medler, T. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02218-2 · Cited by 5
A telomerase em células-tronco hematopoéticas
Perini, S., Silla, L. M. R., & de Andrade, F. M. (2008) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842008000100012 · Cited by 8
Augert, A., & Bernar, D. (2013) · InTech eBooks · doi:10.5772/55519 · Cited by 9
“In accordance with these results, late generation TERC-/deficient mice have been shown to be resistant to multistage skin carcinogenesis [104] and are more resistant to tumour formation in a subset of cancer mouse models [105, 106].”
ResultThe Use of Transgenic Mice in Cancer and Genome Stability Research
Conmy, S. A., & Nasheuer, H. (2009) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-3471-7_17 · Cited by 5
The Role of Telomeres in Liver Disease
Sunami, Y., von Figura, G., Kleger, A., Strnad, P., Hüser, N., & Hartmann, D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00007-4 · Cited by 5
Blasco, M. A. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)08008-7 · Cited by 4
Self-citationTorres-Montaner, A. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.01.003 · Cited by 5
Embryonic Stem Cells: Prospects of Regenerative Medicine for the Treatment of Human Aging
West, M. D. (2010) · Springer eBooks · doi:10.1007/978-90-481-3999-6_14 · Cited by 4
“of telomeres and an increased resistance to cancer in mice (Gonzales-Suarez et al. 2000).”
BackgroundModerate stem-cell telomere shortening rate postpones cancer onset in a stochastic model
Holbek, S., Bendtsen, K. M., & Juul, J. (2013) · Physical Review E · doi:10.1103/physreve.88.042706 · Cited by 3
The absence of telomerase leads to immune response and tumor regression in zebrafish melanoma
Lopes-Bastos, B., Nabais, J., Ferreira, T., Allavena, G., Maï, M. E., Bird, M., Targen, S., Tattini, L., Kang, D., Yue, J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115035 · Cited by 5
Telomerase in hematopoietic stem cells
Perini, S., Silla, L. M. R., & de Andrade, F. M. (2008) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 3
Arsenic-induced mutagenesis and carcinogenesis: A possible mechanism
Maiti, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89847-8.00016-x · Cited by 3
Telomerase and Cancer: A Promising Target
Falchetti, M. L., Pallini, R., & Levi, A. (2004) · American Journal of Cancer · doi:10.2165/00024669-200403010-00001 · Cited by 4
“[75,94-99] Moreover several recent studies have already”
Telomere Structural Dynamics in Genome Integrity Control and Carcinogenesis
Greenberg, R. A., & Rudolph, K. L. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_11 · Cited by 3
Genetic Instability in Cancer: An Optimal Control Problem
Wan, F. Y. M., Sadovsky, A. V., & Komarova, N. L. (2010) · Studies in Applied Mathematics · doi:10.1111/j.1467-9590.2009.00476.x · Cited by 6
Iannilli, F., Zalfa, F., Gärtner, A., Bagni, C., & Dotti, C. G. (2013) · PLoS ONE · doi:10.1371/annotation/e2d5d0e4-fb3a-4d53-a2de-99cd8d045d1c · Cited by 4
Telomere Maintenance and Oncogenesis
Torres-Montaner, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210941 · Cited by 3
“Through senescence, the inherent tendency of telomere shortening to reactivate telomerase or other means of telomere maintenance (ALT), a pre-requisite for cancer development, is abolished [5].”
Telomerase Mutations and Premature Ageing in Humans
Du, H., Bessler, M., & Mason, P. J. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_5 · Cited by 2
Télomères et télomérase : intérêts et perspectives dans le lupus érythémateux systémique
Georgin‐Lavialle, S., Aouba, A., Lepelletier, Y., Gabet, A., & Hermine, O. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.09.032 · Cited by 5
George, A. L., Boulanger, C. A., & Smith, G. H. (2016) · Aging · doi:10.18632/aging.100985 · Cited by 2
“Further the loss (deletion) of the TER RNA substrate has recently been associated with a reduction of tumorigenesis in endocrine tissue in vivo in a transgenic mouse model [40-43].”
BackgroundRol de la telomerasa en la carcinogénesis y en el envejecimiento prematuro
Flórez, V. M. O., & Montaño, C. A. C. (2016) · Revista Médica Sanitas · Cited by 2
Telomere Binding Proteins and Disease
Blasco, M. A. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_12 · Cited by 2
Self-citationKusuma, F., Andrijono, A., Prijanti, A. R., Nuranna, L., Sekarutami, S. M., Sutrisna, B., & Sandra, F. (2020) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v12i1.813 · Cited by 2
Slijepčević, P. (2007) · Acta Medica Academica · Cited by 1
Using mice to unveil the genetics of cancer resistance
van der Weyden, L., & Adams, D. J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.003 · Cited by 3
Hartwig, F. P. (2013) · Journal of Bone Marrow Research · doi:10.4172/2329-8820.1000123 · Cited by 1
Tumorogensis : The Dual Role of Telomerase
Azhar, J. (2009) · Iranian journal of pathology · Cited by 1
Telomere Shortening and Telomerase Activation during Cancer Formation
Rudolph, K. L. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_11 · Cited by 1
Mouse Model: Telomeres and Telomerase in Stem Cell and Cancer
Huang, X., & Ju, Z. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_6 · Cited by 1
Genetics of premature ovarian insufficiency
Serna, J., Varela, E., & García-Velasco, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816561-4.00011-9 · Cited by 2
Cellular Senescence Pathways in Mouse and Human
Wadhwa, R., Hasan, M. K., & Kaul, S. C. (2003) · Springer eBooks · doi:10.1007/978-94-017-0669-8_12 · Cited by 2
Regulation of the Liver Cell Mass
Malek, N. P., Rudolph, K. L., & Diehl, A. M. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch2e · Cited by 1
Hahn, W. C. (2003) · Cancer Research and Treatment · doi:10.4143/crt.2003.35.6.467 · Cited by 1
Metadata
- Authors
- González-Suárez, E., Samper, E., Flores, J. M., & Blasco, M. A.
- Affiliations
- Centro Nacional de Biotecnología (ES)
- Universidad Complutense de Madrid (ES)
- ORCID
- Flores, Juana M.
- Venue
- Nature Genetics
- Published
- 2000-09
- Volume
- 26
- Issue
- 1
- Pages
- 114-117
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1573467049
- Cited by
- 347
- References
- 29
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 11 · 2019: 9 · 2018: 2 · 2017: 5 · 2016: 11 · 2015: 7 · 2014: 7 · 2013: 21 · 2012: 14
- FWCI
- 17.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- telomerase, telomere shortening, skin carcinogenesis, chromosomal instability, lymphoma, teratocarcinoma, epithelial tumors, telomere maintenance, malignant transformation
- MeSH terms
- Animals, Carcinogens, Flow Cytometry, Immunity, Innate, Immunohistochemistry, Mice, Inbred C57BL, Mice, Mutant Strains, Papilloma, Skin, Skin Neoplasms, Tetradecanoylphorbol Acetate, Time Factors, 9,10-Dimethyl-1,2-benzanthracene, Keratinocytes, Tumor Suppressor Protein p53, Proto-Oncogene Proteins p21(ras), Telomere, In Situ Hybridization, Fluorescence, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.